Cajolo, Ritchel B.

HRN: 27-34-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2025
CEFUROXIME 500MG (TAB)
07/09/2025
07/15/2025
PO
500mg
Bid
Pelvic Lap
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: